AU Patent

AU2014201152B2 — Tablet Formulation

Assigned to Bayer New Zealand Ltd · Expires 2015-07-30 · 11y expired

What this patent protects

The invention relates to a tablet formulation including macrocyclic lactone and levamisole anthelmintic agents. The tablet is stable when stored over time and delivers the agents in a manner similar in efficacy to existing oral drench formulations.

USPTO Abstract

The invention relates to a tablet formulation including macrocyclic lactone and levamisole anthelmintic agents. The tablet is stable when stored over time and delivers the agents in a manner similar in efficacy to existing oral drench formulations.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014201152B2
Jurisdiction
AU
Classification
—
Expires
2015-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Bayer New Zealand Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.